Similar articles

• [Polycardiographic evaluation of the cardiotoxicity of adriamycin].

  Villani F, Beretta G, Guindani A, Pagnoni A, Vivarelli S. Villani F, et al. G Ital Chemioter. 1975 Jan-Dec;22(1-2):39-46. G Ital Chemioter. 1975. PMID: 1235351 Italian. No abstract available.
• [Cardiotoxicity of doxorubicin in children].

  Pilon JW, Naeff MS, Taminiau JA. Pilon JW, et al. Ned Tijdschr Geneeskd. 1984 Jul 14;128(28):1339-43. Ned Tijdschr Geneeskd. 1984. PMID: 6482993 Dutch. No abstract available.
• Prevention of doxorubicin-induced congestive heart failure by continuous intravenous infusion in multiple myeloma; a case report and review of the literature.

  Lieverse RJ, Ossenkoppele GJ. Lieverse RJ, et al. Neth J Med. 1991 Feb;38(1-2):33-4. Neth J Med. 1991. PMID: 2030807
• Age-related adriamycin cardiotoxicity in children.

  Pratt CB, Ransom JL, Evans WE. Pratt CB, et al. Cancer Treat Rep. 1978 Sep;62(9):1381-5. Cancer Treat Rep. 1978. PMID: 356987 Review. No abstract available.
• [The cardiotoxicity of anticancer agents].

  Wakasugi S. Wakasugi S. Ryoikibetsu Shokogun Shirizu. 1996;(14):83-7. Ryoikibetsu Shokogun Shirizu. 1996. PMID: 9047803 Review. Japanese. No abstract available.